Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Zilka

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Translational Neuroscience|January 27, 2017
Tau-mediated synaptic damage in Alzheimer's diseaseSantosh Jadhav, Veronika Cubinkova, Ivana Zimova, et al.
Molecular Neurobiology|May 18, 2018
First-in-Rat Study of Human Alzheimer's Disease Tau PropagationTomas Smolek, Santosh Jadhav, Veronika Brezovakova, et al.
Molecular Psychiatry|June 1, 2023
Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer's disease? From preclinical studies to the clinical trialsNeha Basheer, Tomáš Smolek, Imtaiyaz Hassan, et al.
Journal of Alzheimer'S Disease : JAD|October 23, 2010
Hyperphosphorylated truncated protein tau induces caspase-3 independent apoptosis-like pathway in the Alzheimer's disease cellular modelMonika Zilkova, Norbert Zilka, Andrej Kovac, et al.
The Journal of Comparative Neurology|April 11, 2018
A comparative study on pathological features of transgenic rat lines expressing either three or four repeat misfolded tauBernadeta Valachova, Veronika Brezovakova, Ondrej Bugos, et al.
Frontiers in Aging Neuroscience|January 11, 2020
Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of TauopathyTomas Smolek, Veronika Cubinkova, Veronika Brezovakova, et al.
Frontiers in Aging Neuroscience|March 6, 2020
Corrigendum: Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of TauopathyTomas Smolek, Veronika Cubinkova, Veronika Brezovakova, et al.
Neurobiology of Aging|January 4, 2011
First transgenic rat model developing progressive cortical neurofibrillary tanglesPeter Filipcik, Norbert Zilka, Ondrej Bugos, et al.
The European Journal of Neuroscience|August 16, 2008
Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle loadPeter Koson, Norbert Zilka, Andrej Kovac, et al.
FEBS Letters|February 3, 2007
A novel monoclonal antibody DC63 reveals that inhibitor 1 of protein phosphatase 2A is preferentially nuclearly localised in human brainBranislav Kovacech, Eva Kontsekova, Norbert Zilka, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Translational Neuroscience|January 27, 2017
Tau-mediated synaptic damage in Alzheimer's diseaseSantosh Jadhav, Veronika Cubinkova, Ivana Zimova, et al.
Molecular Neurobiology|May 18, 2018
First-in-Rat Study of Human Alzheimer's Disease Tau PropagationTomas Smolek, Santosh Jadhav, Veronika Brezovakova, et al.
Molecular Psychiatry|June 1, 2023
Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer's disease? From preclinical studies to the clinical trialsNeha Basheer, Tomáš Smolek, Imtaiyaz Hassan, et al.
Journal of Alzheimer'S Disease : JAD|October 23, 2010
Hyperphosphorylated truncated protein tau induces caspase-3 independent apoptosis-like pathway in the Alzheimer's disease cellular modelMonika Zilkova, Norbert Zilka, Andrej Kovac, et al.
The Journal of Comparative Neurology|April 11, 2018
A comparative study on pathological features of transgenic rat lines expressing either three or four repeat misfolded tauBernadeta Valachova, Veronika Brezovakova, Ondrej Bugos, et al.
Frontiers in Aging Neuroscience|January 11, 2020
Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of TauopathyTomas Smolek, Veronika Cubinkova, Veronika Brezovakova, et al.
Frontiers in Aging Neuroscience|March 6, 2020
Corrigendum: Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of TauopathyTomas Smolek, Veronika Cubinkova, Veronika Brezovakova, et al.
Neurobiology of Aging|January 4, 2011
First transgenic rat model developing progressive cortical neurofibrillary tanglesPeter Filipcik, Norbert Zilka, Ondrej Bugos, et al.
The European Journal of Neuroscience|August 16, 2008
Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle loadPeter Koson, Norbert Zilka, Andrej Kovac, et al.
FEBS Letters|February 3, 2007
A novel monoclonal antibody DC63 reveals that inhibitor 1 of protein phosphatase 2A is preferentially nuclearly localised in human brainBranislav Kovacech, Eva Kontsekova, Norbert Zilka, et al.
Pageof 8